(Q37741797)

22 August 2017

1 reference

title

Gene-expression-based prognostic assays for breast cancer (English)

1 reference

22 August 2017

1 reference

Chungyeul Kim

1

0 references

Soonmyung Paik

object named as

Soonmyung Paik

series ordinal

2

0 references

language of work or name

English

0 references

publication date

4 May 2010

1 reference

Nature Reviews Clinical Oncology

22 August 2017

1 reference

22 August 2017

7

1 reference

22 August 2017

340-347

1 reference

22 August 2017

6

1 reference

Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay

22 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Commercialized multigene predictors of clinical outcome for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Gene expression profiling predicts clinical outcome of breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Genomic grade index is associated with response to chemotherapy in patients with breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

A gene-expression signature as a predictor of survival in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Technology insight: Application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Direct multiplexed measurement of gene expression with color-coded probe pairs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Quantitative monitoring of gene expression patterns with a complementary DNA microarray

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Molecular portraits of human breast tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Supervised risk predictor of breast cancer based on intrinsic subtypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Converting a breast cancer microarray signature into a high-throughput diagnostic test.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

The MINDACT trial: the first prospective clinical validation of a genomic tool

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Clinical application of the 70-gene profile: the MINDACT trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

TAILORx: trial assigning individualized options for treatment (Rx)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Concordance among gene-expression-based predictors for breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.61

Gene expression-based prognostic and predictive markers for breast cancer: a primer for practicing pathologists.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20440284

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Individualization of therapy using Mammaprint: from development to the MINDACT Trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20440284

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCLINONC.2010.61

1 reference

22 August 2017

1 reference

PubMed ID

20440284